Back to BlackRock, Inc. BlackRock, Inc.

TCRXTCRX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in TSCAN THERAPEUTICS INC

BlackRock, Inc. holds 994,654 shares of TCRX (TSCAN THERAPEUTICS INC), worth $974,860 as of 2026-Q2. The position was decreased (-46.0% shares).

Current Value

$974,860

Current Shares

994,654

Total Value Change

-$14.1M

Total Shares Change

-4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
994,654
-46.0%
$974,8600.0%$0.98
0
2026-Q1
Decreased
1.8M
-0.4%
$1.9M0.0%$1.03
0
2025-Q4
Decreased
1.8M
-22.4%
$1.8M0.0%$1.03
0
2025-Q3
Decreased
2.4M
-7.2%
$4.3M0.0%$1.74
0
2025-Q2
Decreased
2.6M
-47.4%
$3.7M0.0%$1.40
0
2025-Q1
Decreased
4.9M
-1.7%
$6.7M0.0%$1.35
0
2024-Q4
New
5M
-
$15.1M0.0%$3.00
39

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used